Multiple failings led to a patient with Crohn's disease having a hysterectomy without giving informed consent, an ombudsman ...

AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

Many other conditions can mimic the symptoms of prostate cancer, both in its early or advanced stages. Here's what you need ...